Nephrology Dialysis Transplantation 2005 20(11):2584; doi:10.1093/ndt/gfi235
Irbesartan reduces creatinine clearance in type 1 diabetic children with renal hyperfunction: a randomized, double-blind, placebo-controlled trial
In the second paragraph, line 7, the passage ... if they had renal hyperfunction, defined as a CCR>20 ml/min/1.73 m2 body surface area should read ... if they had renal hyperfunction, defined as a CCR>120 ml/min/1.73 m2 body surface area. The complete and correct passage is below:
Children were eligible to participate if they had renal hyperfunction, defined as a CCR>120 ml/min/1.73 m2 body surface area, published in the October 2005 issue of Nephrology Dialysis Transplantation.
The authors would like to apologise for this error.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||